886 related articles for article (PubMed ID: 19513549)
81. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
Zhang D; Yu M; Xu T; Xiong B
Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
[TBL] [Abstract][Full Text] [Related]
82. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer.
Ishigami S; Sakamoto A; Uenosono Y; Nakajo A; Okumura H; Matsumoto M; Setoyama T; Arigami T; Uchikado Y; Arima H; Natsugoe S; Aikou T
J Surg Res; 2008 Aug; 148(2):205-9. PubMed ID: 17936797
[TBL] [Abstract][Full Text] [Related]
83. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
[TBL] [Abstract][Full Text] [Related]
84. A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer.
Chien CC; Chang CC; Yang SH; Chen SH; Huang CJ
Oncol Rep; 2006 Apr; 15(4):919-26. PubMed ID: 16525680
[TBL] [Abstract][Full Text] [Related]
85. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
86. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.
Märten A; Büchler MW; Werft W; Wente MN; Kirschfink M; Schmidt J
J Immunother; 2010; 33(2):219-24. PubMed ID: 20139773
[TBL] [Abstract][Full Text] [Related]
87. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
88. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
89. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer.
Park IJ; Choi GS; Jun SH
Anticancer Res; 2009 Oct; 29(10):4303-8. PubMed ID: 19846991
[TBL] [Abstract][Full Text] [Related]
90. Identification of glypican-3 as a novel tumor marker for melanoma.
Nakatsura T; Kageshita T; Ito S; Wakamatsu K; Monji M; Ikuta Y; Senju S; Ono T; Nishimura Y
Clin Cancer Res; 2004 Oct; 10(19):6612-21. PubMed ID: 15475451
[TBL] [Abstract][Full Text] [Related]
91. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
Schneider J; Schulze G
Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
[TBL] [Abstract][Full Text] [Related]
92. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
93. [Evaluation of RCAS1 as serum tumor marker for pancreatic cancer].
Yang YC; Zhao YP; Liao Q; Zhang TP; Hu Y; Dai MH
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):999-1001. PubMed ID: 19957811
[TBL] [Abstract][Full Text] [Related]
94. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
Nakayama T; Watanabe M; Teramoto T; Kitajima M
Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
[TBL] [Abstract][Full Text] [Related]
95. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
Anticancer Res; 1999; 19(4A):2477-80. PubMed ID: 10470177
[TBL] [Abstract][Full Text] [Related]
96. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
97. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
[TBL] [Abstract][Full Text] [Related]
98. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
[TBL] [Abstract][Full Text] [Related]
99. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
[TBL] [Abstract][Full Text] [Related]
100. Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.
D'Armento G; Daniele L; Mariani S; Ottaviani D; Mussa A; Cassoni P; Sapino A; Bussolati G
Int J Surg Pathol; 2009 Apr; 17(2):93-8. PubMed ID: 19074466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
